BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15831677)

  • 1. Fos-related antigen 1 modulates malignant features of glioma cells.
    Debinski W; Gibo DM
    Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
    Belguise K; Kersual N; Galtier F; Chalbos D
    Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.
    Plate KH; Breier G; Farrell CL; Risau W
    Lab Invest; 1992 Oct; 67(4):529-34. PubMed ID: 1434531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.
    Vallone D; Battista S; Pierantoni GM; Fedele M; Casalino L; Santoro M; Viglietto G; Fusco A; Verde P
    EMBO J; 1997 Sep; 16(17):5310-21. PubMed ID: 9311991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility.
    Tkach V; Tulchinsky E; Lukanidin E; Vinson C; Bock E; Berezin V
    Oncogene; 2003 Aug; 22(32):5045-54. PubMed ID: 12902987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
    Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
    Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
    Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
    Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
    Guerin C; Luddy C; Abounader R; Lal B; Laterra J
    Biochem Biophys Res Commun; 2000 Jun; 273(1):287-93. PubMed ID: 10873600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials.
    Andersen H; Mahmood S; Tkach V; Cohn M; Kustikova O; Grigorian M; Berezin V; Bock E; Lukanidin E; Tulchinsky E
    Oncogene; 2002 Jul; 21(31):4843-8. PubMed ID: 12101423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
    Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
    Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.
    Casalino L; Bakiri L; Talotta F; Weitzman JB; Fusco A; Yaniv M; Verde P
    EMBO J; 2007 Apr; 26(7):1878-90. PubMed ID: 17347653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.
    Suswam E; Li Y; Zhang X; Gillespie GY; Li X; Shacka JJ; Lu L; Zheng L; King PH
    Cancer Res; 2008 Feb; 68(3):674-82. PubMed ID: 18245466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
    Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
    Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodal promotes growth and invasion in human gliomas.
    Lee CC; Jan HJ; Lai JH; Ma HI; Hueng DY; Lee YC; Cheng YY; Liu LW; Wei HW; Lee HM
    Oncogene; 2010 May; 29(21):3110-23. PubMed ID: 20383200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
    J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells.
    Liu G; Ding W; Liu X; Mulder KM
    Mol Carcinog; 2006 Aug; 45(8):582-93. PubMed ID: 16637060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene.
    Song Y; Qian L; Song S; Chen L; Zhang Y; Yuan G; Zhang H; Xia Q; Hu M; Yu M; Shi M; Jiang Z; Guo N
    Mol Immunol; 2008 Jan; 45(1):137-43. PubMed ID: 17572495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses.
    Morishita H; Saito F; Kayama H; Atarashi K; Kuwata H; Yamamoto M; Takeda K
    Int Immunol; 2009 Apr; 21(4):457-65. PubMed ID: 19251936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.